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Abstract 
Alternative solutions need to be developed to overcome the growing problem of multi-drug 
resistant bacteria. This study explored the possibility of creating complexes of antibiotics with 
metal ions, thereby increasing their activity. Analytical techniques such as isothermal titration 
calorimetry and nuclear magnetic resonance were used to examine the structure and 
interactions between Cu(II), Ag(I) or Zn(II) and β-lactam antibiotics. The metal- β-lactam 
complexes were also tested for antimicrobial activity, by micro-broth dilution and disk diffusion 
methods, showing a synergistic increase in the activity of the drugs, and enzymatic inhibition 
assays confirming inhibition of β-lactamases responsible for resistance. The metal-antibiotic 
complex concept was proven to be successful with the activity of the drugs enhanced against β-
lactamase-producing bacteria. The highest synergistic effects were observed for complexes 
formed with Ag(I). 
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1. Introduction 
The treatment of infectious diseases with β-lactam antibiotics is threatened by the evolution of 
superbugs. Careless use of antibiotics has led to the evolution of multi-drug resistant (MDR) 
bacteria resulting in untreatable infections, and this rise and spread of resistant bacteria is a 
serious threat for health systems across the globe.[1] With the ongoing increase in drug 
resistance, the treatment of bacterial diseases by antibiotics is becoming less effective, and 
there are very few new antibiotics in the clinical pipeline,[2] necessitating the development of 
alternative approaches.[3] The possibility of modifying existing commercially available drugs to 
overcome MDR is a favorable approach, saving costs and time compared to the design and 
development of completely new drugs.[1, 4-6] 
One way to selectively target bacteria in the human body is to focus on cellular components 
that are unique to bacteria. The mode of action of β-lactam antibiotics involves the inactivation 
of transpeptidases by inhibition of the crosslinking step essential for the synthesis of 
peptidoglycan. Formation of the cell wall is blocked, leading to bacterial death induced through 
osmotic pressure.[7-10] To prevent this destruction, bacteria have developed a variety of 
different resistance strategies, with mechanisms based on the degradation of the β-lactam 
antibiotic through hydrolysis of the lactam ring being the most dynamic approach.[9] Different 
types of β-lactamases have evolved to disable new generations of β-lactam antibiotics, with 
metallo-β-lactamases (MBLs) being one of the major causes of widespread antibacterial 
resistance towards the important carbapenem class of antibiotics.[11, 12] These 
metallohydrolases require at least one metal ion in the active site to coordinate to the 
nucleophile required for hydrolysis.[7-10, 13-17] In recent years, several groups have been 
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developing compounds that inhibit some of the MBLs, but to date no universally active MBL 
inhibitor has emerged.[18-24] 
Since conventional approaches to develop MBL inhibitors have been unsuccessful so far, 
alternative methods are needed. One possible tactic to increase the activity of antibiotics 
involves their complexation with metal cations. Metal ions such as Cu(II), Ag(I) or silver 
nanoparticles are known both for their antimicrobial properties and for their ability to increase 
the activity of different antibiotics.[25-32] Coordination of drugs with certain transition metals is 
known to influence the drug´s antimicrobial properties and biological activity.[29, 30] Most of 
the reported antibiotic complexes bind the metal ions through electron donor groups.[25-29] 
An understanding of the relationship between the structure and chemical compositions of 
active drugs can be crucial to decipher the mode of drug action. In this study, attempts to 
enhance the activity of β-lactam antibiotics through complexation with metal ions are 
described. Specifically, Zn(II) was used as it is an essential cofactor for MBLs, whereas Cu(II) and 
Ag(I) were selected due to their inherent antimicrobial properties. Isothermal titration 
calorimetry (ITC) and nuclear magnetic resonance (NMR) studies were applied to investigate 
binding modes between ampicillin and penicillin G with these metal ions; cefuroxime was 
included specifically to record reproducible in vitro inhibition data (Figure 1). These antibiotics 
were also selected because they are already severely affected in their effectiveness due to 
evolved resistance. Based on the determined molar ratio, the effects of complexation on the 
antimicrobial activity were then examined using micro-broth dilution assays against sensitive 
and lactam-resistant strains. Finally, kinetic enzymatic studies were carried out to demonstrate 
that an observed improvement in activity against resistant strains resulted from β-lactamase 
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inhibition, and indeed a decrease of β-lactamase activity towards cefuroxime in the presence of 
Ag(I) ions was observed. 
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2. Materials and Methods 
2.1 Materials 
All chemicals, including the antibiotics ampicillin, penicillin G, cefuroxime and meropenem as 
the respective sodium salts, were purchased from Sigma Aldrich unless otherwise stated and 
used without further purification. Deuterated water was purchased from Cambridge Isotope 
Laboratories. Metal salts selected were AgNO3, CuCl2, ZnCl2, and Zn(OAc)2. Nitrate was chosen 
as counter ion for silver due to its good solubility in the buffer employed, chloride and acetate 
for copper and zinc as they are biocompatible as drug salts. Water for all the aqueous solutions 
was sourced from a Milli-Q purification system. IMP-1, a class B zinc metallo-β-lactamase was 
expressed and purified by transforming competent BL21 (DE3) Escherichia coli cells with a 
pET47b-IMP-1 vector using the protocol developed by Vella et al.[33] For the disk diffusion, and 
micro-broth dilution antimicrobial assays the following bacteria strains were used: Escherichia 
coli ATCC 25922 FDA control strain, IMP-4 metallo-β-lactamase producing E. coli (CR48),[34, 35] 
NDM-4-producing E. coli (CR53),[34] CTX-M-15-producing E. coli (Ec71)[36] and E. coli TOP 10, 
Klebsiella pneumoniae ATCC 700603 MDR, Acinetobacter baumannii ATCC 19606, Pseudomonas 
aeruginosa ATCC 27853, methicillin-resistant Staphylococcus aureus ATCC 43300. All ATCC 
strains were obtained from ATCC (American Type Culture Collection). All other E. coli were 
clinical strains E. coli which have been characterized for the antimicrobial resistance markers 
and sequence types.[34-36] 
2.2 Methods 
2.2.1 ITC measurements 
ITC experiments were performed using a MicroCal Omega Auto iTC200 (GE Healthcare). The 
measurements were carried out at a temperature of 298.15 K under an atmosphere of nitrogen, 
with a stirring speed of 1000 rpm and a reference power of 10 µcal/s. The reference cell was 
filled with ultrapure water (250 µL), the sample cell (220 µL) and the syringe (40 µL) with the 
respective sample in 10 mM HEPES buffer solution (pH of 7.4), with injections repeated three 
times consecutively. Furthermore, water to water measurements were performed between 
each experiment. The association constant (K), the change in enthalpy (ΔH), entropy (ΔS) and 
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the stoichiometry (N) were fitted with a single site binding model. Calculations using the 
equation ΔG = -RT ln(K) (where T is the absolute temperature and R the universal gas constant) 
revealed Gibbs free energy (ΔG). As suggested by the device company, the first raw data point 
was removed to minimize additional effects during the first injection (0.4 µL over a period of 
0.8 s). Control experiments including every binding participant and the buffer were carried out 
to determine dilution effects [injection setup: Volume (2 µL), duration (2 s), spacing (150 s), 
filter period (5 s)]. The setup for the binding measurements consisted of titrating solutions of 
metal salts with concentrations from 1.5 mM up to 4 mM into solutions of the antibiotic salts 
with a concentration of 0.4 mM. The experiments comprised either 20 injections (each 2 µL), 
30 injections (each 1.3 µL) or 40 injections (each 1 µL) with a range of spacing from 300 s to 
1200 s. 
2.2.3 NMR 
Interactions between the antibiotics and silver ions were investigated by NMR spectroscopy 
using a Bruker AVANCE III 600 MHz instrument. The pH was adjusted to 7.4 by adding NaOH to a 
HEPES stock solution (10 mM with 5 v% D2O). The antibiotics ampicillin and penicillin G were 
dissolved in the HEPES buffer and transferred into the NMR tube right before each 
measurement. The NMR tube was covered in aluminum foil (due to the light-sensitivity of Ag(I)) 
after adding the required volume of Ag(I)/HEPES solution. Nine different antibiotic to Ag(I) ratios 
were tested: 1:0.0; 1:0.25; 1:0.5; 1:0.75; 1:1.0; 1:1.5; 1:2.0; 1:3.0; 1:4.0 (details about samples 
preparation: Supporting information (SI), Table S1). 
2.2.4 Antimicrobial micro-broth dilution assay 
The different metal and antibiotic complexes were prepared immediately before the 
experiment by dissolving and mixing them in distilled water. All bacteria strains were cultured in 
Mueller Hinton (MH) broth at 37C overnight with shaking (180 RPM). A sample of each culture 
was then diluted 40-fold in fresh MH-broth and incubated at 37C for 2 - 3 h. The compounds 
were serially diluted two-fold across the wells, with concentrations ranging from 0.03 μg/mL to 
256 μg/mL and plated in non-binding surface (NBS) plates (Corning, 3641). The bacteria cultures 
were diluted and 50 µL added to each well of the compound-containing 96-well plates to the 
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final cell concentration of 5105 CFU/mL, and a final compound concentration range of 
0.06 μg/mL to 128 μg/mL. All plates were covered and incubated at 37C for 24 h. Minimum 
Inhibitory Concentrations (MICs) were determined visually, being defined as the lowest 
concentration showing no visible growth. 
2.2.5 Disk-test of β-lactam antibiotics 
The antimicrobial activity of several complexes of ampicillin and penicillin G with metal ions was 
also tested in a disk assay against E. coli strains that produce β-lactamase as a resistance 
mechanism against a wide spectrum of β-lactam antibiotics: four different E. coli strains (CR48, 
CR53, Ec71 and TOP10) were used for this purpose. Two of the multidrug-resistant E. coli strains 
(CR48 and CR53) produce NDM-4 (New Delhi metallo-β-lactamase) or IMP-4 metallo-β-
lactamase, respectively. The third strain, Ec71, expresses an extended spectrum β-lactamase, 
CTX-M-15, which is able to cleave cefotaxime (third generation cephalosporin antibiotic). E. coli 
TOP10 is a susceptible E. coli strain without any resistance gene. 
Colonies of the bacteria strains were added to different tubes with MH-broth until an optical 
density at 600 nm (OD600) of around 0.2 a.u. was reached. The bacteria suspension was then 
inoculated on to the MH agar plates in order to perform disk susceptibility testing. The 
appropriate disks were placed. Blank disks were also used by adding the penicillin G solution 
and its complexes on to these disks. Blank disks were also used to test the inhibitory activity of 
the metal compounds by themselves. For ampicillin and its complexes, standard disks containing 
10 µg of ampicillin (Becton Dickinson) were used, with the metal ion solution added before 
placing on the agar plate. For penicillin G, blank disks were used and 10 µg of the antibiotic was 
added as a solution. Complexes of antibiotics and metal ions of different molar ratios were 
prepared: ampicillin /Ag(I) 1:1, 1:5 and 1:10 and for penicillin G/Ag(I) 1:0.5, 1:5 and 1:10. 
Furthermore, the solutions of the antibiotics and the metal solutions were added separately on 
a blank disk. 
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2.2.6 Enzymatic study 
The β-lactamase activity of the purified enzyme IMP-1 metallo-β-lactamase towards cefuroxime 
was measured spectrophotometrically by monitoring the depletion of the absorbance at 
λ = 260 nm, a change induced through the cleavage of the β-lactam ring by the enzyme.[21] 
Reactions were performed for 60 s at 25°C in 20 mM HEPES (pH 7.4) with a final enzyme 
concentration of 16 nM IMP-1 metallo-β-lactamase. Michaelis-Menten curves were generated 
for assays conducted at different concentrations of AgNO3 (0 µM, 2 µM and 5 µM). Reaction 
rates were determined from the initial linear portion of the reaction progress. The Michaelis-
Menten parameters of each of the assays (kcat (the maximum velocity of the enzyme expressed 
as the number of moles of substrate converted to product by one mole of enzyme in one 
second), KM (the concentration of substrate needed to reach half maximum velocity) and 
kcat/KM) as well as the inhibition constant (Ki) and mode were determined using GraphPad 
Prism 7 software. All the measurements were carried out using a Varian Cary 50-BIO 
spectrophotometer connected to a Peltier Thermostat system. The reactions were carried out 
without the addition of extra zinc to the buffer. 
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3. Results and Discussion 
3.1 Characterization of complexes between metal ions and antibiotics 
3.1.1 ITC studies 
The investigation of complex formation between antibiotics and metal ions by ITC revealed 
exothermic interactions between ampicillin, penicillin G and cefuroxime with CuCl2 and AgNO3 
and endothermic interactions with ZnCl2 and Zn(OAc)2. No interactions could be found between 
CaCl2 (at a concentration of 4 mM) and the examined antibiotics. The strongest interactions 
occurred with AgNO3 (ΔG up to -7.5 kcal mol
-1), followed by CuCl2 (ΔG around -7.0 kcal mol
-1) 
and Zn(OAc)2 (ΔG ≤ 6.7 kcal mol
-1) (Table 1). The complexation of ampicillin and cefuroxime with 
AgNO3 occurred with a strong enthalpically driven reaction (ΔH up to - 5.9 kcal mol
-1). The 
stability and purity of the resulting metal-antibiotic complexes were determined using LC-MS 
(SI, 2 LC-MS experiments). No cleavage of the lactam bond catalyzed through the presence of 
metal ions was observed on the timescale of the measurements by LC-MS. 
CuCl2 to ampicillin and penicillin G: The titration of 4 mM of CuCl2 to a 0.4 mM solution of 
ampicillin [number of injection: 40, spacing time: 600 s, Volume per injection: 1 μL] revealed an 
interaction between one Cu(II) cation and two anionic ampicillin molecules. In the experiments 
consisting of 4 mM CuCl2 titrated to 0.4 mM penicillin G [spacing time expanded to 1200 s] the 
stoichiometry was found to be one to one (SI, Figure S1). The values of ΔG were in the same 
range, only small differences could be found in the exothermic enthalpy (higher values for 
penicillin G with ΔH = -2.8 kcal mol-1 compared to -1.5 kcal mol-1 for ampicillin) and the entropy 
(higher increase for titrations involving ampicillin with T∙ΔS = 5.4 kcal mol-1). 
AgNO3 to ampicillin and penicillin G: Interactions were determined by titrating 3 mM AgNO3 to 
0.4 mM of ampicillin [number of injection: 40, spacing time: 600 s, Volume per injection: 1 μL] 
and 1.5 mM AgNO3 titrating to 0.4 mM penicillin G, subsequently (SI, Figure S1 and S2). The 
measurements revealed an equimolar ratio for Ag(I) cation and anionic ampicillin and a binding 
mode of one Ag (I) cation to two anionic penicillin G molecules. Compared to the interactions 
with Cu(II), the interactions showed a comparable Gibbs energy and an entropically driven 
reaction for the antibiotic penicillin G but an enthalpic interaction in case of ampicillin. 
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AgNO3 to cefuroxime: In this case 2.5 mM AgNO3 was titrated into 0.4 mM cefuroxime [number 
of injection: 30, spacing time: 600 s, Volume per injection: 1.3 µL]. It was found that Ag(I) 
complexed with two cefuroxime molecules showing an exothermic interaction (Figure 2). The 
value of the association constant (K) was found to be in between the value for the titration of 
Ag(I) to ampicillin and that for Ag(I) to penicillin G. The ΔG value was in the same range of the 
previous mentioned Ag(I) complexes. However, the binding of Ag(I) to cefuroxime (-5.9 kcal mol
-
1) proceeded with a higher enthalpy when compared to Ag(I) binding to ampicillin and penicillin 
G (-4.6 kcal mol-1 and - 2.1 kcal mol-1 respectively). 
ZnCl2/ Zn(OAc)2 to ampicillin and penicillin G: To check the influence of the counterion on the 
interactions with the antibiotics, both ZnCl2 and Zn(OAc)2 were examined (SI, Figure S1). 
Titrations of 4 mM ZnCl2 and Zn(OAc)2 to 0.4 mM ampicillin and penicillin G [number of 
injection: 20, spacing time: 300 s, Volume per injection: 2 μL] revealed interactions to be around 
a molar ratio of one Zn(II) cation to two anionic antibiotic molecules for zinc chloride, and one 
Zn(II) cation to five anionic antibiotic molecules for zinc acetate. The overall processes were 
constant with an endothermic enthalpy in both cases and therefore a strong entropically driven 
process. The thermodynamic data were influenced by the counterion: ΔG and ΔH increased by a 
factor about 1.1 and T∙ΔS by 1 kcal mol-1 using the acetate salt instead of chloride. 
ITC summary: ITC experiments revealed different binding modes between the antibiotics and 
the metal ions. Depending on the metal cation and its oxidation state, the stoichiometries of the 
metal-β-lactam complexes were found to be either 1:2 or 1:1 in case of AgNO3 and CuCl2. 
Related to the antibiotics ampicillin and penicillin G the different values for the stoichiometry 
could be explained due to the presence of an extra amino group in ampicillin (Figure 1). NMR 
studies were performed to confirm our speculations on the involvement of the amino group in 
the complex formation. 
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3.1.2 NMR studies 
To confirm the ITC observations, NMR experiments were performed to obtain structural 
information about the complexation of these antibiotics with silver ions. The NMR 
measurements showed moderate interactions between the antibiotics and Ag(I) ions based on 
concentration dependent proton shifts: The higher the concentration of Ag(I), the higher the 
observed shift of the proton signals in comparison to the starting material (Figure 3 and 4, 
Table S2 and S3, SI). The strongest interactions were detected for the protons H9 in both cases 
(penicillin G and ampicillin, Figure 5 and 6), and for H7-NH in case of penicillin G. For ampicillin 
this particular proton was not visible. The results provide evidence that the Ag(I) is coordinated 
by the amide nitrogen N7 and the sulfur atom in the thiethane ring on both cases. The protons 
H8 and H9 show two doublets around 5.5 ppm for penicillin G (Figure 3) but not for ampicillin 
(Figure 4) where only a singlet could be found. Interestingly, this singlet was found to split up 
into the expected two signals by the continuous addition of Ag(I). This provides evidence that 
Ag(I) stabilizes a rapidly isomerizing pair of structures, with a change of the three-dimensional 
orientation of the molecule in an aqueous solution mimicking physiological-like conditions. The 
NMR measurements, with observed linear proton shifting trend, are in a good agreement with 
the ITC results, displaying the Ag(I)/antibiotic ratio reaches 1:2 for the penicillin G complex 
(based on the proton H7-NH), and 1:1 ratio for the ampicillin complex (based on overall proton 
shifts). Even though further increases of the silver concentrations were leading to slightly higher 
shifts, especially for the H9 and H13 in the ampicillin complex, the trends were visible until 
reaching these ratios (Figure 5 and 6). 
 
3.2 Influence of metal ions on the antibiotic activities 
3.2.1 Antimicrobial micro-broth dilution assay 
Broth microdilution assays to determine MICs (minimum inhibitory concentrations) were 
performed to investigate the influence of complexes between β-lactam-antibiotics and metals 
on bacterial growth. Both Gram-positive and Gram-negative bacteria strains were examined. All 
experiments were conducted with vancomycin as a positive inhibitor control for Gram-positive 
bacteria and colistin as a positive inhibitor control for Gram-negative bacteria. As expected, 
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experiments with penicillin G and ampicillin as examples of early generation β-lactam antibiotics 
showed antibacterial effects only against the control strain of E. coli, with almost no effect on 
other Gram-negative and MDR strains. Varying results were seen with the metal salts alone: 
AgNO3 had an antibacterial effect against all examined strains in contrast to CuCl2 and Zn(OAc)2 
where only a very low antimicrobial effect was visible. 
For several complexes between antibiotics and metal ions synergistic effects were observed. 
Synergy occurs if the combined effect of two agents is greater than the sum of their individual 
effects. For the quantification of the synergistic effects the fractional inhibitory concentration 
index (FICI) was calculated with the following formula, whereas FICI values below ≤ 0.5 indicate 
synergistic effects[37] : 
𝐹𝐼𝐶𝐼 =
𝑀𝐼𝐶𝑎𝑛𝑡𝑖𝑏𝑖𝑜𝑡𝑖𝑐 𝑖𝑛 𝑡ℎ𝑒 𝑐𝑜𝑚𝑝𝑙𝑒𝑥
𝑀𝐼𝐶𝑎𝑛𝑡𝑖𝑏𝑖𝑜𝑡𝑖𝑐 𝑎𝑙𝑜𝑛𝑒
+
𝑀𝐼𝐶𝑚𝑒𝑡𝑎𝑙 𝑖𝑛 𝑡ℎ𝑒 𝑐𝑜𝑚𝑝𝑙𝑒𝑥
𝑀𝐼𝐶𝑚𝑒𝑡𝑎𝑙 𝑎𝑙𝑜𝑛𝑒
 
 
The complex of ampicillin with Ag(I) in the stoichiometry determined in the previous ITC 
experiments showed the lowest MIC values for its minimal inhibitory concentration with FICI 
values < 0.5 and therefore the best inhibition of bacterial growth. With the ratio of 1:1 for 
ampicillin and Ag(I) the highest synergistic effects could be observed (Table 2). Complexes with 
a 1:10 stoichiometry showed synergistic effects as well but in relation to the higher 
concentration of AgNO3 the synergistic effects appeared less significant, though this was strain 
dependent: For A. baumannii and P. aeruginosa nearly 10-fold lower ampicillin concentrations 
were required for the 1:10 stoichiometry compared to the 1:1, with similar absolute Ag(I) 
concentrations. The same trend could be observed for the complexes of penicillin G with Ag(I) in 
the stoichiometry 1:0.5 and 1:5. In regards to the other metal salts, only complexes between 
ampicillin and CuCl2 displayed antibacterial effects against the control strain of E. coli. 
Experiments involving Zn(II) revealed no activity against any of the bacteria strains. The 
complexes corresponding to the molar ratio determined in ITC experiments showed the best 
relation between activity and metal-ion concentration. 
Different trends were observed for the Gram-positive strain S. aureus (MRSA) (Table 2). The 
complexes with Cu(II) showed high synergistic effects with both penicillin G and ampicillin and 
even for the Zn(II) complexes synergistic effects were visible. The lowest MIC values were 
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obtained for the complexes of penicillin G with Cu(II) and Ag(I). Interestingly ampicillin and 
penicillin G alone showed higher potency against Gram-positive strains than Gram-negative 
strains, whereas Ag(I) showed a reduced activity. Furthermore, a preliminary MIC assay with 
NDM-4 and IMP-4 producing bacteria strains confirmed the synergistic effects of Ag(I) and the 
β-lactam antibiotics (Table S5, SI). The complexes used in this study should not cause toxicity, as 
most of the MIC values are below the LD50 values for these metal ions described in literature, 
with only one exception in case of the complex between penicillin G and Cu(II) (PenG/Cu 
1:10 complex) where the Cu(II) concentration is higher than it’s reported LD50, but this 
particular complex employed a large excess of copper and was less potent than PenG/Cu 1:1 
(for details please see Table S6, SI). To confirm the results acquired within these MIC 
experiments, further investigations of the complexes were conducted as part of a disk diffusion 
susceptibility test (Table S7, SI, samples preparation). 
 
3.2.2 Disk Diffusion assay 
For this assay, zones free of bacterial growth (zone of inhibition) surrounding the disk containing 
antibiotic or antibiotic with metal ion were evaluated (Figure S3, Table 3). The diameter of these 
zones is proportional to the antimicrobial activity of the different compounds. The antimicrobial 
activity of ampicillin was tested together with different concentrations of Cu(II), Ag(I) and Zn(II) 
ions within the first trial. It was clearly visible that ampicillin, Cu(II) ions or Zn(II) ions alone had 
no activity against the NDM-4 and IMP-4-producing strains. Only Ag(I) showed a moderate 
antimicrobial activity against all strains tested (Table 3). Furthermore, for the complex of 
ampicillin and Ag(I) in an equimolar ratio, the diameter of the inhibition zone was the same as 
for Ag(I) alone. However, the concentration of Ag(I) in the complex is only half of the Ag(I) 
concentration of the disc with Ag(I) alone. The inhibition zone of the complex ampicillin and 
Ag(I) in the ratio 1:10 was larger than for the equimolar complex, resulting from the increased 
concentration of Ag(I) ions. This indicates that, for ampicillin and Ag(I) complexes, synergistic 
effects were observed, whereas the highest effect in respect of the metal concentration was 
obtained for the ratio determined by ITC. Penicillin was also tested in combination with Ag(I) 
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against the NDM-4 and IMP-4-producing strains, and also showed the highest synergistic effects 
at the ratio determined by ITC experiments.  
Finally, the antimicrobial activity of penicillin G and ampicillin was tested against two additional 
E. coli strains (Ec71 resistant to 3rd generation cephalosporins and a susceptible E. coli TOP 10) 
to evaluate whether the observed synergistic effects are limited only to MBL-producing E. coli 
strains. The E. coli Top 10 strain was included as a negative control as it is not resistant to β-
lactam antibiotics, whereas strain Ec71 produces a broad-spectrum β-lactamase that is not 
metal ion dependent. Due to the fact that the complexes with Cu(II) and Zn(II) showed no 
activity (data not shown), only the effect of complexes with Ag(I) were analyzed. While the 
growth of the TOP 10 strains appeared to be minimally affected by the presence of either the 
ampicillin or penicillin G complexes (the inhibition zone remained, more or less, constant at 10 
mm) the growth of the Ec71 strain was closely related to that of the NDM-producing E. coli 
strain CR53. In the Ec71 system the complexes of penicillin G and ampicillin with Ag(I) showed 
synergistic effects; the strongest effect (relative to the concentration of Ag(I)) was observed for 
the ratio obtained by ITC (1:0.5). Thus, in summary, both the micro-broth dilution and the disk 
diffusion studies lead to the conclusion that the complexation of metal ions by β-lactam 
antibiotics can increase their antimicrobial activity through synergistic effects. 
 
3.2.3 Enzymatic study 
Kinetics assays were conducted to assess the ability of Ag(I) to inhibit the degradation of 
cefuroxime by IMP-1 metallo-β-lactamase (Table S8 to S10, SI, raw data). The activity of IMP-1 
metallo-β-lactamase on cefuroxime was visibly inhibited upon addition of Ag(I) (Table 4, 
Figure 7). The assays were run using 0 µM, 2 µM and 5 µM of IMP-1 metallo-β-lactamase 
showing a Ki (the amount of inhibitor needed to reduce the activity of the enzyme by half) of 
0.6 µM. These results, along with those from the disk diffusion test, indicate that Ag(I) can act as 
an effective inhibitor of β-lactamase activity, therefore enhancing the antimicrobial activity 
against resistant strains when used in combination with β-lactam antibiotics. 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
16 
 
4. Conclusions 
The observed synergism of the complexes between β-lactam antibiotics and some metal ions 
could be due to inhibition of β-lactamase activity. ITC and NMR experiments revealed 
interactions between Ag(I) or Cu(II) and β-lactam antibiotics, with these complexes showing an 
increase in activity of the antibiotic in the presence of the metal ions. However, Zn(II) complexes 
showed an endothermic binding by ITC, and negligible antimicrobial effect. Microbiological 
experiments revealed the highest synergistic effects of the complexes tended to match the 
molar ratio determined by ITC. Moreover, the activity of IMP-1 enzymes could be inhibited in 
the presence of complexes between Ag(I) and cefuroxime, demonstrating that at least some of 
the antimicrobial enhancement was due to prevention of lactam hydrolysis. These finding 
indicate that Ag(I) is synergistically working with β-lactam antibiotics by inhibiting and/or 
blocking the β-lactamase activity allowing the antibiotics to be active against bacteria and a 
potential lactam/lactamase inhibitor combination to be used in the clinic. This study also 
demonstrated that the counterion influenced the binding process, hence future plans also 
include testing of different metal salts, as well as different oxidation and physical states of 
metals including nanoparticles, organoparticles and colloidal forms. 
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Tables and Figures 
 
Figure 1: Chemical structure of the semisynthetic antibiotics penicillin G (compound 1), 
ampicillin (compound 2, with extra amine group highlighted), cefuroxime (compound 3) and 
meropenem (compound 4). These antibacterial agents are all β-lactam antibiotics and used for 
the treatment of a broad spectrum of infection. 
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Table 1: The thermodynamic data of interactions between Cu(II), Zn(II), Ag(I) with ampicillin, 
penicillin G or cefuroxime in 10 mM HEPES buffer (pH 7.4) at a constant temperature of 298 K. 
All experiments were performed at a concentration (conc.) of 0.4 mM for each antibiotic. T is 
the absolute Temperature, K is the association constant, ΔG is the change in Gibbs energy, ΔH is 
the change in enthalpy, ΔS is the change in entropy and N is the stoichiometry. Interactions 
determined by ITC experiments revealed Ag(I) as the most promising binding partner. 
System  Conc. (metal salt) 
[mM] 
K 
 [10
5
 M
-1
] 
ΔG 
[10
3
 cal mol
-1
] 
ΔH 
[10
3
 cal mol
-1
] 
T∙ΔS 
[10
3
 cal mol
-1
] 
N 
CuCl2 to ampicillin 4 1.3 ± 0.7 -7.0 ± 0.6 -1.5 ± 0.2 5.4 ± 0.2 0.51 ± 0.03 
CuCl2 to penicillin G 4 1.0 ± 0.3 -6.8 ± 0.6 -2.8 ± 0.2 4.0 ± 0.2 1.22 ± 0.04 
AgNO3 to ampicillin 3 2.6 ± 0.5 -7.5 ± 0.2 -4.6 ± 1.7 2.9 ± 1.5 1.05 ± 0.12 
AgNO3 to penicillin G 1.5 3.0 ± 1.2 -7.4 ± 0.2 -2.1 ± 0.2 5.3 ± 0.4 0.43± 0.21 
AgNO3 to cefuroxime 2.5 2.8 ± 0.1 -7.4 ± 0.1 -5.9 ± 0.2 1.6 ± 0.2 0.61 ± 0.01 
ZnCl2 to ampicillin 4 0.1 ± 0.1 -5.5 ± 0.7 0.7 ± 0.3 6.2 ± 0.4 0.58 ± 0.12 
ZnCl2 to penicillin G 4 0.1 ± 0.1 -5.4 ± 0.6 0.6 ± 0.1 6.1 ± 0.2 0.46 ± 0.07 
Zn(OAc)2 to ampicillin 4 0.3 ± 0.1 -6.2 ± 0.1 1.1 ± 0.2 7.2 ± 0.3 0.21 ± 0.08 
Zn(OAc)2 to penicillin G 4 0.9 ± 0.1 -6.7 ± 0.1 0.5 ± 0.1 7.2 ± 0.2 0.19 ± 0.04 
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Figure 2: Results for the titration of 2.5 mM AgNO3 to 0.4 mM cefuroxime in 10 mM HEPES 
buffer (pH 7.4) using 30 injections. The upper panel shows the heat response given by each 
injection and the lower panel shows the integrated heat curve points normalized per mole of 
injectant as a function of molar ratio. A One-site model was used to determine an N, K, ΔH and 
ΔS value of 0.601 ± 6.06 x10-3, 2.74 x 105 ± 3.94 x 104 M, -6.15 x 103 ± 0.119 x 103 cal/mol and 
4.25 cal/mol/K respectively. This shows an exothermic interaction between one silver ion and 
two cefuroxime molecules. 
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Figure 3: Comparison of the proton shifts (1H-NMR) of penicillin G with nine different ratios of 
Ag(I) in HEPES buffer (pH 7.4). By increasing the Ag(I) concentration the proton signals get 
shifted more, especially H9 at about 5.5 ppm and H7-NH at about 8.7 ppm. 
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Figure 4: Comparison of the proton shifts (1H-NMR) of ampicillin with nine different ratios of 
Ag(I) in HEPES buffer (pH 7.4). By increasing the Ag(I) concentration the proton signals get 
shifted more, especially H9 at about 5.5 ppm, which becomes split into two signals. 
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Figure 5: Difference between the shifts for the proton signals of the respective antibiotic and 
different ratios of Ag(I) in HEPES buffer (pH 7.4): a) penicillin G (PenG), b) ampicillin (Amp). 
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Figure 6: Comparison of the respective proton shifts (1H-NMR) of ampicillin and penicillin G in 
HEPES buffer (pH 7.4) between the antibiotic shifts without silver salt and the observed shifts 
for the highest Ag(I) to antibiotic ratio (4:1). 
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Table 2: Micro-broth dilution results for the complexes between ampicillin and penicillin G with 
different metal ions. Complexes with Cu(II) and Zn(II) showed very low activity whereas the MIC 
(Minimum Inhibitory Concentration) values of the complex between AgNO3 and ampicillin 
showed the most promising results against resistant bacteria strains. Fractional inhibitory 
concentration index (FICI) values were calculated for the most promising complexes. FICI values 
below ≤ 0.5 indicate synergistic effects, 0.5 < FICI < 4 define no interaction, FICI > 4 define 
antagonism. The FICI values <0.5 are written in bold. Duplicate values shown. The starting 
concentration of the respective antibiotics was 2.56 mg/mL. Shaded fields show those 
concentrations where the activity was better than either of the individual components. 
Compound  
Metal 
salt 
Starting 
Conc. 
E. coli 
K. 
pneumo
niae 
A. baumannii P. aeruginosa S. aureus 
ATCC 25922 
ATCC 
700603 
ATCC 19606 ATCC 27853 ATCC 43300 
 FDA control MDR Type QC strain MRSA 
[mg/mL] MIC [μg/mL]* 
(FICI) 
colistin 
 0.03/0.06 
0.03/ 
0.06 
0.06 0.06/0.125  
vancomycin      1 
ampicillin  4 >128 >128 >128 8/16 
penicillin G  32/64 >128 >128 >128 8/16 
AgNO3 2.56 2 4 2 2/4 16 
CuCl2* 2 H2O 2.56 >128 >128 >128 >128 >128 
Zn(OAc)2 * 
2 H2O 
2.56 >128 >128 >128 >128 >128 
Amp/Ag(I) 1:1 
1.17 
2 
(0.96) 
4 
(<0.48) 
2 
(0.47) 
2 
(<0.47/<0.24) 
2/4 
(0.31/0.36) 
Amp/Ag(I) 
1:10 
11.7 
1/0.5 
(2.5/1.3) 
1 
(<1.1) 
0.125/0.25 
(<0.28/<0.57) 
0.25 
(<0.57/<0.28) 
1 
(0.41/0.12) 
PenG/Ag(I) 
1:0.5 
0.61 
2/4 
(0.30/0.53) 
8 
(<0.54) 
2 
(<0.25) 
2/4 
(<0.25/<0.27) 
4 
(0.56/0.30) 
PenG/Ag(I)  
1:5 
3.05 
2/4 
(1.2/2.4) 
4 
(<1.22) 
1 
(<0.60) 
1/2 
(<0.60/<0.61) 
2 
(0.40/0.27) 
Amp/Cu(II) 
1:0.5 
0.59 
8/16 
(<2.0/<4.0) 
>128 >128 >128 
32 
(<4.1/<2.1) 
Amp/Cu(II) 1:5 
2.94 
64/128 
(<17/<33) 
>128 >128 >128 
2/4 
(<0.27/<0.29) 
PenG/Cu(II) 
1:1 
1.22 >128 >128 >128 >128 
1 
(<0.13/<0.07) 
PenG/Cu(II) 
1:10 
12.2 >128 >128 >128 >128 
4 
(<0.65/<0.27) 
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Amp/Zn(II) 
1:10 
7.90 >128 >128 >128 >128 
2/4 
(<0.3/<0.35) 
PenG/Zn(II) 
1:10 
7.50 >128 >128 >128 >128 
16/32 
(<2.4/<2.7) 
*MIC values are provided for antibiotics, metal salts, and antibiotics in the complexes, while the MIC values of 
metals in the complexes, necessary to calculate the FICI, are provided in Table S4, SI. 
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Table 3: Zone of inhibition measured for the disk diffusion tests for complexes between 
ampicillin and penicillin G with silver ions tested against E. coli expressing different β-
lactamases. The best ratio of antimicrobial activity related to the Ag(I) concentration could be 
obtained for the complexes with the stoichiometry obtained by ITC experiments. 
 
 
 
 
 
 
 
 
  
   E. coli  E. coli  E. coli  E. coli 
Metal salt conc. 
[µg/mL] 
CR48 (IMP-4) CR53 (NDM-4) CTX-M-15 (Ec71 
producing CTX-M-15) 
TOP 10 
Compound  Zone of inhibition (diameter) [mm] 
AgNO3 only 1.68 10 7 8 10 
Amp/Ag(I) 1:1 0.76 10 8 8.5 10 
Amp/Ag(I) 1:5 3.8   8.5 10 
Amp/Ag(I) 1:10 7.6 14 9 10 10 
Amp only  0 0 0 10 
PenG/Ag(I) 1:0.5 0.38 8 7 8 8 
PenG/Ag(I) 1:5 1.9 11 7 9 10 
PenG/Ag(I) 1:10 3.8 11.5 9 10 10 
PenG only  0 0 0 0 
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Table 4: Kinetic parameters of the silver inhibition of the hydrolysis of cefuroxime by 16 nM 
IMP-1 metallo-β-lactamase using varying inhibitor concentrations. The catalytic rate kcat (the 
maximum velocity of the enzyme expressed as the number of moles of substrate converted to 
product by one mole of enzyme in one second) of IMP-1 is reduced and the KM (the 
concentration of substrate needed to reach half maximum velocity) is increased as the 
concentration of Ag(I) increases, resulting in a decrease in the catalytic efficiency expressed as 
kcat/KM (/sec/µM). 
[AgNO3] 
[μM] 
Kcat 
[/sec] 
KM 
[µM] 
Kcat/KM 
[/sec/µM] 
0 16.6 5.92 2.80 
2 15.3 24.1 0.635 
5 9.88 27.6 0.358 
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Figure 7: Michaelis-Menten curves for the hydrolysis of cefuroxime by IMP-1 metallo-β-
lactamase with varying concentrations of AgNO3 (0 µM, 2 µM and 5 µM). As the concentration 
of AgNO3 increases the kcat decreases (16.6 /sec, 15.3 /sec and 9.88 /sec for 0 µM, 2 µM and 
5 µM respectively) and the KM increases (5.92 µM, 24.1 µM and 27.6 µM for 0 µM, 2 µM and 
5 µM respectively) resulting in a decrease in catalytic efficiency as the concentration of inhibitor 
increases (2.80 /sec/µM, 0.635 /sec/µM and 0.358 /sec/µM for 0 µM, 2 µM and 5 µM 
respectively). 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
32 
 
Graphical abstract 
Synergistic effect was observed in the complexes of β-lactam antibiotics formed with silver(I). 
Interactions between metal ions and antibiotics were explored by isothermal titration calorimetry. 
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Highlights 
 Complex formation between β-lactam antibiotics and metal ions (Ag(I), Cu(II), Zn(II)) was 
investigated. 
 Thermodynamics of complex formation were assessed by ITC. 
 The activity of all metal:antibiotic complexes was tested in minimal inhibitory concentration 
(MIC) assays. 
 The Ag(I):β-lactam antibiotic complex formation was confirmed by NMR, and potency was 
verified by enzymatic assay showing inhibition of β-lactamases responsible for resistance. 
